| Serial Number | 88664224 |
| Word Mark | VYDAPTIV |
| Filing Date | Tuesday, October 22, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 29, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 3, 2020 |
| Goods and Services | Pharmaceutical preparations containing polypeptides, antibodies, or antibody derivatives for the treatment and prophylaxis of cancer and immune system diseases and disorders, and autoimmune system diseases, namely, neurological and neuromuscular diseases and disorders, gastrointestinal diseases, nervous system diseases and disorders, respiratory system diseases, lymphatic system diseases, primary and secondary immunodeficiency disorders, genetic autoimmune diseases, severe combined immunodeficiency diseases, immune complex diseases, and immunodeficiency diseases, including, allergies, asthma, diabetes, rheumatoid arthritis, multiple sclerosis, lupus, Hashimoto's, inflammatory bowel disease, Guillain-Barre, psoriasis, chronic inflammatory demyelinating polyneuropathy (CIPD), Graves' disease, myasthenia gravis, and transplant rejection diseases, and blood disorders, all of the foregoing to exclude antibiotics and pharmaceutical preparations for the treatment and prophylaxis of infectious diseases |
| Goods and Services | Therapeutic protein molecules used in the manufacture of pharmaceutics and biologically-derived medical preparations; all the foregoing to exclude such molecules relating to antibiotics and pharmaceutical preparations for the treatment and prophylaxis of infectious diseases |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields relating to polypeptides, antibodies or antibody derivatives, in relation to the treatment and prophylaxis of cancer, immune system diseases and disorders, and autoimmune system diseases, namely, neurological and neuromuscular diseases and disorders, gastrointestinal diseases, nervous system diseases and disorders, respiratory system diseases, lymphatic system diseases, primary and secondary immunodeficiency disorders, genetic autoimmune diseases, severe combined immunodeficiency diseases, immune complex diseases, and immunodeficiency diseases, including, allergies, asthma, diabetes, rheumatoid arthritis, multiple sclerosis, lupus, Hashimoto's, inflammatory bowel disease, Guillain-Barre, psoriasis, chronic inflammatory demyelinating polyneuropathy (CIPD), Graves' disease, myasthenia gravis, and transplant rejection diseases, and blood disorders, all of the foregoing to exclude research and development in relation to antibiotics and the treatment and prophylaxis of infectious diseases |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 28, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 28, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 28, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aptevo Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98121 |
| Party Name | Aptevo Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98121 |
| Event Date | Event Description |
| Tuesday, May 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, May 29, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, November 8, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, November 7, 2022 | SOU EXTENSION 5 GRANTED |
| Friday, October 28, 2022 | SOU EXTENSION 5 FILED |
| Monday, November 7, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, October 28, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, April 30, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 28, 2022 | SOU EXTENSION 4 GRANTED |
| Thursday, April 28, 2022 | SOU EXTENSION 4 FILED |
| Thursday, April 28, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, October 30, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 28, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, October 28, 2021 | SOU EXTENSION 3 FILED |
| Thursday, October 28, 2021 | SOU TEAS EXTENSION RECEIVED |
| Friday, April 30, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 28, 2021 | SOU EXTENSION 2 GRANTED |
| Wednesday, April 28, 2021 | SOU EXTENSION 2 FILED |
| Wednesday, April 28, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 28, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 26, 2020 | SOU EXTENSION 1 GRANTED |
| Monday, October 26, 2020 | SOU EXTENSION 1 FILED |
| Monday, October 26, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 28, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 3, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 12, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 28, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 28, 2020 | ASSIGNED TO EXAMINER |
| Monday, October 28, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 25, 2019 | NEW APPLICATION ENTERED |